Oncologix Tech Inc logo

OCLG - Oncologix Tech Inc Share Price

$0 0.0  0.0%

Last Trade - 28/05/20

Sector
Healthcare
Size
Micro Cap
Market Cap £94.2k
Enterprise Value £2.70m
Revenue £3.74m
Position in Universe th / 6363
Bullish
Bearish
Unlock OCLG Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Financial Summary
FINANCIAL BRIEF: : For the nine months ended 31 May 2015, Oncologix Tech Inc revenues increased 34% to $3.6M. Net loss before extraordinary items increased 30% to $1.5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Interest and finance charges increase of 72% to $1.1M (expense), General and administrative increase of 36% to $1.4M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

OCLG Revenue Unlock OCLG Revenue

Net Income

OCLG Net Income Unlock OCLG Revenue

Normalised EPS

OCLG Normalised EPS Unlock OCLG Revenue

PE Ratio Range

OCLG PE Ratio Range Unlock OCLG Revenue

Dividend Yield Range

OCLG Dividend Yield Range Unlock OCLG Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
OCLG EPS Forecasts Unlock OCLG Revenue
Profile Summary

Oncologix Tech, Inc. (Oncologix) is a medical device and healthcare services holding company in North America. The Company, through its subsidiaries, operates and manufactures medical device products and delivers Personal Healthcare Services. For its customers, Oncologix provides medical devices and State licensed healthcare services. For its shareholders, Oncologix operates business divisions that build, maintain and nourish shareholder value. The Company operates in two segments, including Personal Care Services and Medical Device Manufacturing. Personal Care Service segment consists of the services of Angels of Mercy, Inc. Medical Device Manufacturing segment consists of the products of Dotolo Research Corporation. The Company’s wholly owned subsidiaries include Dotolo Research Corporation (DRC), Angels of Mercy, Inc. (AOM), Interpretel Inc., Telplex International and International Environment Corporation.

Directors
Last Annual August 31st, 2014
Last Interim May 31st, 2015
Incorporated December 10, 1997
Public Since February 11, 1987
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Providers & Services
Index
Exchange OTC Markets Group
Shares in Issue 773,125,725
Free Float (0.0%)
Eligible for
ISAs
SIPPs
OCLG Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for OCLG
Upcoming Events for OCLG
Frequently Asked Questions for Oncologix Tech Inc
What is the Oncologix Tech Inc share price?

As of 28/05/20, shares in Oncologix Tech Inc are trading at $0, giving the company a market capitalisation of £94.2k. This share price information is delayed by 15 minutes.

How has the Oncologix Tech Inc share price performed this year?

Shares in Oncologix Tech Inc are currently trading at $0 and the price has moved by 50% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Oncologix Tech Inc price has moved by 47.83% over the past year.

What are the analyst and broker recommendations for Oncologix Tech Inc?

There are no analysts currently covering Oncologix Tech Inc.

When will Oncologix Tech Inc next release its financial results?

Oncologix Tech Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2016-05-31
What is the Oncologix Tech Inc dividend yield?

Oncologix Tech Inc does not currently pay a dividend.

Does Oncologix Tech Inc pay a dividend?

Oncologix Tech Inc does not currently pay a dividend.

When does Oncologix Tech Inc next pay dividends?

Oncologix Tech Inc does not currently pay a dividend.

How do I buy Oncologix Tech Inc shares?

To buy shares in Oncologix Tech Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Oncologix Tech Inc?

Shares in Oncologix Tech Inc are currently trading at $0, giving the company a market capitalisation of £94.2k.

Where are Oncologix Tech Inc shares listed? Where are Oncologix Tech Inc shares listed?

Here are the trading details for Oncologix Tech Inc:

Country of listing: United States
Exchange: OTC
Ticker Symbol: OCLG
What kind of share is Oncologix Tech Inc?

We were not able to load our ranking data for Oncologix Tech Inc

Is there a Oncologix Tech Inc share price forecast 2020?

We were not able to load any forecast data for Oncologix Tech Inc.

How can I tell whether the Oncologix Tech Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Oncologix Tech Inc. Over the past six months, the relative strength of its shares against the market has been 61.75%. At the current price of $0, shares in Oncologix Tech Inc are trading at 25.09% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Oncologix Tech Inc PE Ratio?

We were not able to find PE ratio data for Oncologix Tech Inc.

Who are the key directors of Oncologix Tech Inc?

Oncologix Tech Inc's management team is headed by:

Michael Kramarz - CHM
Vickie Hart - CEX
Roy Erwin - PRE
Harold Halman - COO
Who are the major shareholders of Oncologix Tech Inc?

Here are the top five shareholders of Oncologix Tech Inc based on the size of their shareholding:

Similar to OCLG
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.